Comparative Safety and Effectiveness of Warfarin or Rivaroxaban Versus Apixaban in Patients With Advanced CKD and Atrial Fibrillation: Nationwide US Cohort Study.
慢性腎臟疾病和房顫患者中華法林或利伐羅班與阿哌沙班的比較安全性和有效性:美國全國性群體研究。
Am J Kidney Dis 2024-02-26
Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy: The ARCADIA Randomized Clinical Trial.
Apixaban用於預防房性心臟病患者憑證性中風後的復發:ARCADIA隨機臨床試驗。
JAMA 2024-03-19
Anticoagulation with osocimab in patients with kidney failure undergoing hemodialysis: a randomized phase 2 trial.
腎衰竭患者進行血液透析接受奧索西邁抗凝治療:一項隨機2期試驗。
Nat Med 2024-02-24
A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis.
一項階段二的隨機對照試驗評估了在血液透析患者中使用 fesomersen 進行抗血栓治療的效果。
Kidney Int 2024-03-27
Safety and efficacy of apixaban versus vitamin K antagonists in patients undergoing dialysis: a systematic review and meta-analysis.
透析患者中apixaban與維生素K拮抗劑的安全性和有效性:系統性回顧與荟萃分析。
Ren Fail 2024-05-21